Docoh
Loading...

136 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
20 Sep 21
Definitive proxy
2:51pm
to independent stockholders because, among other reasons, a potential suitor may offer such stockholders a premium for their shares of common stock as compared
PRE 14A
PCSA Processa Pharmaceuticals Inc
1 Sep 21
Preliminary proxy
4:46pm
of which we are aware to accumulate shares of our common stock or obtain control of the Company. A takeover may be beneficial to independent
424B5
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Prospectus supplement for primary offering
4:46pm
December 31, 2020 have been audited by BD & Company, Inc., an independent registered public accounting firm, as set forth in their report thereon … audited by BD & Company, Inc., an independent registered public accounting firm, as set forth in their report thereon and incorporated herein
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
of capital stock or repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock. (i) Independent Accountants. BD … in the Registration Statement and included or incorporated by reference in the Prospectus, are independent public accountants as required by the Securities Act
8-K
EX-5.1
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
Exhibit 5.1 ATTORNEYS AT LAW one independent drive, suite 1300 Jacksonville, Florida 32202-5017 904.359.2000 TEL 904.359.8700 FAX www.foley.com
S-3
EX-23.1
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Shelf registration
4:02pm
Exhibit 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement
S-3
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Shelf registration
4:02pm
, of agent for service) with a copy to: Michael B. Kirwan John J. Wolfel, Jr. Foley & Lardner LLP One Independent Drive, Suite 1300 Jacksonville … Annual Report on Form 10-K for the fiscal year ended December 31, 2020, have been audited by BD & Company, Inc., an independent registered public
S-3
EX-5.1
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Shelf registration
4:02pm
Exhibit 5.1 ATTORNEYS AT LAW LLP ONE INDEPENDENT DRIVE, SUITE 1300 JACKSONVILLE, FL 32202-5017 904.359.2000 TEL 904.359.8700 FAX WWW.FOLEY.COM
S-8
EX-5.1
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Registration of securities for employees
4:02pm
Exhibit 5.1 ATTORNEYS AT LAW LLP ONE INDEPENDENT DRIVE, SUITE 1300 JACKSONVILLE, FL 32202-5017 904.359.2000 TEL 904.359.8700 FAX WWW.FOLEY.COM
S-8
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Registration of securities for employees
4:02pm
, address and telephone number of agent for service) Copy to: Michael B. Kirwan John J. Wolfel, Jr. Foley & Lardner LLP One Independent Drive … & Lardner LLP (filed herewith) Consent of Independent Registered Public Accounting Firm, BD & Co. Inc. (filed herewith) Consent of Foley & Lardner LLP
S-8
EX-23.1
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Registration of securities for employees
4:02pm
Exhibit 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
, Sublicense Consideration and payments required by this Article VI. Ocuphire shall have the right, once annually at its own expense, to have an independent … Date and/or is developed by such Party independent of any use of the Ocuphire Intellectual Property. (b) Sole Inventions. Each Party shall exclusively
8-K
PCSA Processa Pharmaceuticals Inc
10 Jun 21
Submission of Matters to a Vote of Security Holders
5:30pm
Non-Votes The appointment of BD & Company Inc. as the independent registered public accounting firm 2021 was ratified based on the following votes
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
. as the independent registered public accounting firm of Processa Pharmaceuticals, Inc. for the fiscal year ending December 31, 2021; and To transact … OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FORM BENEFICIAL OWNERSHIP OF COMMON STOCK STOCKHOLDER PROPOSALS STOCKHOLDER COMMUNICATIONS
424B3
PCSA Processa Pharmaceuticals Inc
12 Apr 21
Prospectus supplement
1:44pm
, have been audited by BD & Company, Inc., an independent registered public accounting firm, as set forth in their report thereon and incorporated
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
served as an independent Director on the Questcor Board of Directors. As an independent director, Dr. Young, representing Questcor, worked … was involved with Questcor as an independent director and as its CSO, Questcor transitioned to an orphan drug specialty pharmaceutical company, moving from
S-3
EX-23.1
PCSA Processa Pharmaceuticals Inc
1 Apr 21
Shelf registration
8:00pm
Exhibit 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement
S-3
PCSA Processa Pharmaceuticals Inc
1 Apr 21
Shelf registration
8:00pm
, of agent for service) with a copy to: Michael B. Kirwan John J. Wolfel, Jr. Foley & Lardner LLP One Independent Drive, Suite 1300 Jacksonville … ., an independent registered public accounting firm, as set forth in their report thereon and incorporated herein by reference. Such consolidated
S-3
EX-5.1
PCSA Processa Pharmaceuticals Inc
1 Apr 21
Shelf registration
8:00pm
Exhibit 5.1 ATTORNEYS AT LAW One Independent Drive, Suite 1300 Jacksonville, FL 32202-5017 904.359.2000 TEL 904.359.8700 FAX www.foley.com
10-K
2020 FY
EX-23.1
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
Exhibit 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement